SVB Leerink started coverage on shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) in a report issued on Tuesday, Marketbeat.com reports. The firm issued an outperform rating and a $12.00 target price on the stock. A number of other brokerages have also recently weighed in on PYXS. HC Wainwright reissued a buy rating and issued […]
Pyxis Oncology (NASDAQ:PYXS) Coverage Initiated at SVB Leerink theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Pyxis Oncology (NASDAQ:PYXS) Coverage Initiated by Analysts at SVB Leerink themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.